University of Pennsylvania is working on a treatment for solid tumours and its only known investor is HLB Pharmaceutical.

Stanford Law School has participated in early funding for Medchart, split across seed and series A rounds.

Leaps by Bayer has led the seed round for Edifice Health, which spun out of Stanford University and also attracted Ahren Innovation Capital.

Synthesia was co-founded by researchers at UCL, Stanford, Cambridge and TUM to build a platform that generates video content using artificial intelligence.

UPMC Enterprises has co-led a seed round for the gene therapy developer.

University of Sheffield spinout Rinri Therapeutics has collected $13.9m from investors including Boehringer Ingelheim Venture Fund and UCB Ventures.

UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.

Originally known as Cambridge Crops, the MIT and Tufts-linked company has added $16m to its coffers.

IU Ventures has returned for a series B round for Encamp, having previously taken part in a series A round year.

UGA spinout Aruna Bio is working on a treatment for neurodegenerative diseases such as Parkinson’s and multiple sclerosis.